Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment.
暂无分享,去创建一个
Z. Massy | B. Lacour | G. Lambrey | T. Drüeke | V. Witko-Sarsat | M. Thévenin | V. Witko-Sarsat | T. Nguyen-Khoa | J. de Bandt | M. Kebede | L. Salama | L. Salama
[1] Z. Massy,et al. Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients. , 1999, Kidney international.
[2] D. Tarng,et al. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. , 1999, Kidney international.
[3] P. Stenvinkel,et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. , 1999, Kidney international.
[4] C. Wanner,et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. , 1999, Kidney international.
[5] P. Jungers,et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. , 1998, Journal of immunology.
[6] P. Ridker,et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. , 1998, Circulation.
[7] J. Cristol,et al. Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] G. London,et al. Atherosclerosis and arteriosclerosis in chronic renal failure. , 1997, Kidney international.
[9] Y. Wada,et al. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. , 1997, Kidney international.
[10] P. McNamee,et al. Susceptibility of VLDL to oxidation in patients on regular haemodialysis. , 1997, Atherosclerosis.
[11] U. Beisiegel,et al. Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia. , 1997, Atherosclerosis.
[12] T. Miyata,et al. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] C. Morris,et al. Ascorbate promotes low density lipoprotein oxidation in the presence of ferritin. , 1996, Biochimica et biophysica acta.
[14] P. Jungers,et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. , 1996, Kidney international.
[15] P. Jungers,et al. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. , 1996, Free radical biology & medicine.
[16] C. Combe,et al. Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron. , 1995, Nephron.
[17] D. Girelli,et al. Selenium status, fatty acids, vitamins A and E, and aging: the Nove Study. , 1994, The American journal of clinical nutrition.
[18] G. Bellomo,et al. Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? , 1994, Kidney international.
[19] P. De Sole,et al. Serum coenzyme Q10 in uremic patients on chronic hemodialysis. , 1994, Nephron.
[20] L. Hunt,et al. Comparative mortality from cardiovascular disease in patients with chronic renal failure. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] J. Paul,et al. Lipid peroxidation abnormalities in hemodialyzed patients. , 1993, Nephron.
[22] M. Kazatchkine,et al. Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: a randomized prospective study. , 1991, Nephron.
[23] O. Aruoma,et al. Action of hypochlorous acid on the antioxidant protective enzymes superoxide dismutase, catalase and glutathione peroxidase. , 1987, The Biochemical journal.
[24] B. Descamps-Latscha,et al. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. , 1985, Kidney international.
[25] Y. Yawata,et al. Abnormal red cell metabolism in patients with chronic uremia: Nature of the defect and its persistence despite adequate hemodialysis. , 1975, Blood.